Company: RNGE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024206
Chunk: 255

Company: RANGE IMPACT, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 3
Chunk 255
---
 and we do not anticipate paying any cash dividends in the foreseeable future.

The
continued operation and expansion of our business will require substantial funding. We have paid no cash dividends on any of our capital
stock to date and we currently intend to retain our available cash to fund the development and growth of our business. Any determination
to pay dividends in the future will be at the discretion of our Board of Directors and will depend upon our results of operations, financial
condition, contractual restrictions, restrictions imposed by applicable law and other factors our Board of Directors deems relevant.
We do not anticipate paying any cash dividends on our common stock in the foreseeable future. Any return to stockholders will therefore
be limited to the appreciation of their stock, which may never occur.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds: None

Item
3. Defaults Upon Senior Securities: None

Item
4. Mine Safety Disclosures:

The
information concerning mine safety violations and other regulatory matters is filed as Exhibit 95 to this Form 10-Q pursuant to the requirements
of Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K (17 CFR 229.104).

Item
5. Other Information: None

33

Item
6. Exhibits

    Exhibit
    Number
     
    Description
    of Exhibit

    2.1
     
    Agreement and Plan of Merger, dated September 14, 2011, by and between Stevia First Corp. and Legend Mining Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

    3.1.1
     
    Articles of Incorporation of Stevia First Corp. (Incorporated by reference to Exhibit 3.1 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 6, 2008 (File No. 333-152830).)

    3.1.2
     
    Certificate of Amendment of Articles of Incorporation of Vitality Biopharma, Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on July 19, 2016.)

    3.1.3
     
    Articles of Merger